相似文献
1
Turmeric and green tea: a recipe for the treatment of B-chronic lymphocytic leukemia.
Clin Cancer Res. 2009 Feb 15;15(4):1123-5. doi: 10.1158/1078-0432.CCR-08-2791.
2
Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG.
Clin Cancer Res. 2009 Feb 15;15(4):1250-8. doi: 10.1158/1078-0432.CCR-08-1511.
3
Component in green tea helps kill leukemia cells.
Mayo Clin Womens Healthsource. 2004 Sep;8(9):3.
4
Quantitation of chemopreventive synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells.
Carcinogenesis. 1998 Mar;19(3):419-24. doi: 10.1093/carcin/19.3.419.
5
Curcumin as a permeability enhancer enhanced the antihyperlipidemic activity of dietary green tea extract.
BMC Complement Altern Med. 2019 Jun 13;19(1):129. doi: 10.1186/s12906-019-2545-1.
6
VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia.
Blood. 2004 Aug 1;104(3):788-94. doi: 10.1182/blood-2003-08-2763. Epub 2004 Mar 2.
7
Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies.
Leuk Res. 2006 Jun;30(6):707-12. doi: 10.1016/j.leukres.2005.10.020. Epub 2005 Dec 1.
8
Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species.
Clin Cancer Res. 2005 Aug 15;11(16):6040-9. doi: 10.1158/1078-0432.CCR-04-2273.
9
Interaction of tea catechin (-)-epigallocatechin gallate with lipid bilayers.
Biophys J. 2009 Feb;96(3):1026-35. doi: 10.1016/j.bpj.2008.11.007.
10
Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances.
Mutat Res. 1999 Jul 16;428(1-2):305-27. doi: 10.1016/s1383-5742(99)00057-5.
引用本文的文献
1
Protective Effects of Curcumin against Alcoholic Fatty Liver.
Curr Med Chem. 2025;32(9):1702-1717. doi: 10.2174/0929867331666230815113921.
2
Integrative Hematology: State of the Art.
Int J Mol Sci. 2023 Jan 15;24(2):1732. doi: 10.3390/ijms24021732.
3
Color Stability of Different Denture Teeth Following Immersion in Staining Solutions.
Front Dent. 2022 Feb 1;19:6. doi: 10.18502/fid.v19i6.8551. eCollection 2022.
4
Molecular Action of Polyphenols in Leukaemia and Their Therapeutic Potential.
Int J Mol Sci. 2021 Mar 17;22(6):3085. doi: 10.3390/ijms22063085.
5
Antioxidant Activity of Spices and Their Impact on Human Health: A Review.
Antioxidants (Basel). 2017 Sep 15;6(3):70. doi: 10.3390/antiox6030070.
6
Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids.
Curr Genomics. 2017 Feb;18(1):3-26. doi: 10.2174/1389202917666160803165447.
7
Epigallocatechin-3-Gallate Inhibition of Myeloperoxidase and Its Counter-Regulation by Dietary Iron and Lipocalin 2 in Murine Model of Gut Inflammation.
Am J Pathol. 2016 Apr;186(4):912-26. doi: 10.1016/j.ajpath.2015.12.004. Epub 2016 Mar 8.
8
B-Cell Disorders and Curcumin.
Integr Cancer Ther. 2017 Sep;16(3):255-257. doi: 10.1177/1534735415622013. Epub 2015 Dec 16.
9
Broad targeting of resistance to apoptosis in cancer.
Semin Cancer Biol. 2015 Dec;35 Suppl(0):S78-S103. doi: 10.1016/j.semcancer.2015.03.001. Epub 2015 Apr 28.
10
Antimutagenic and anticancer activity of Darjeeling tea in multiple test systems.
BMC Complement Altern Med. 2014 Sep 2;14:327. doi: 10.1186/1472-6882-14-327.
本文引用的文献
1
Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG.
Clin Cancer Res. 2009 Feb 15;15(4):1250-8. doi: 10.1158/1078-0432.CCR-08-1511.
2
Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.
Clin Cancer Res. 2008 Oct 1;14(19):6228-36. doi: 10.1158/1078-0432.CCR-07-5177.
3
Phase II trial of curcumin in patients with advanced pancreatic cancer.
Clin Cancer Res. 2008 Jul 15;14(14):4491-9. doi: 10.1158/1078-0432.CCR-08-0024.
4
Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins.
Cancer Lett. 2008 Oct 8;269(2):199-225. doi: 10.1016/j.canlet.2008.03.009. Epub 2008 May 13.
5
Curcumin: from ancient medicine to current clinical trials.
Cell Mol Life Sci. 2008 Jun;65(11):1631-52. doi: 10.1007/s00018-008-7452-4.
6
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
Blood. 2008 Jun 15;111(12):5446-56. doi: 10.1182/blood-2007-06-093906. Epub 2008 Jan 23.
7
Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer.
Mol Cancer Ther. 2007 Apr;6(4):1276-82. doi: 10.1158/1535-7163.MCT-06-0556.
8
Curcumin-induced cell cycle arrest and apoptosis in human acute promyelocytic leukemia HL-60 cells via MMP changes and caspase-3 activation.
Anticancer Res. 2006 Nov-Dec;26(6B):4361-71.
9
Medicinal plants from Peru: a review of plants as potential agents against cancer.
Anticancer Agents Med Chem. 2006 Sep;6(5):429-44. doi: 10.2174/187152006778226486.
10
Preclinical assessment of curcumin as a potential therapy for B-CLL.
Am J Hematol. 2007 Jan;82(1):23-30. doi: 10.1002/ajh.20757.
Zotero 插件